Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CEFPODOXIME vs CEFTAZIDIME: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CEFPODOXIME vs CEFTAZIDIME: Safety Overview

Metric CEFPODOXIME CEFTAZIDIME
Total FAERS Reports 398 3,158
Deaths Reported 19 696
Death Rate 4.8% 22.0%
Hospitalizations 257 1,503
Average Patient Age 50.0 yrs 52.0 yrs
% Female Patients 58.2% 43.3%
FDA Approval Date N/A Apr 28, 1989
Manufacturer N/A Hospira, Inc.
Route N/A INTRAVENOUS
Marketing Status N/A Discontinued